CAS 1401223-22-0

PI-1840

Description:

PI-1840, identified by its CAS number 1401223-22-0, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized as a small molecule with a specific structure that allows it to interact with biological targets, often related to cellular signaling pathways. The compound is typically evaluated for its efficacy in modulating various biological processes, which may include anti-inflammatory or anti-cancer activities. Its solubility, stability, and bioavailability are critical factors that influence its pharmacological profile. Additionally, PI-1840 may undergo various forms of testing, including in vitro and in vivo studies, to assess its safety and effectiveness. As with many compounds in drug development, understanding its mechanism of action, potential side effects, and interactions with other substances is essential for determining its viability as a therapeutic agent. Further research is necessary to fully elucidate its properties and potential applications in clinical settings.

Formula: C₂₂H₂₆N₄O₃

Synonyms:

• N-isopropyl-2-(4-propylphenoxy)-N-((3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl)methyl)acetamide
• PI 1840;PI1840
• CS-2559
• N-(1-methylethyl)-2-(4-propylphenoxy)-N-[[3-(3-pyridinyl)-1,2,4-oxadiazol-5-yl]methyl]-acetamide
• PI-1840

PI-1840

CAS: 1401223-22-0

Formula: C₂₂H₂₆N₄O₃

Purity: 98%

Molecular weight: 394.4668

Ref: IN-DA009CEA

PI-1840

CAS: 1401223-22-0

PI-1840

Purity: ≥98%

Molecular weight: 394.47g/mol

Ref: 54-BUP10611

PI-1840 [Proteasome Inhibitor]

CAS: 1401223-22-0

Ref: 7W-GW0508

PI-1840

CAS: 1401223-22-0

PI-1840 is a reversible and selective chymotrypsin-like (CT-L) inhibitor, with little proteasome proteolytic effects on trypsin-like (T-L) and PGPH-L.

Formula: C₂₂H₂₆N₄O₃

Purity: 98.82%

Color and Shape: Solid

Molecular weight: 394.47

Ref: TM-T6941

PI-1840

CAS: 1401223-22-0

PI-1840 is a small molecule that can inhibit the proteasome and thus induce cancer cell apoptosis. PI-1840 has been shown to be an inhibitor of the immunoproteasome, which is an enzyme involved in protein degradation. PI-1840 also sensitizes cancer cells to bortezomib, a drug that inhibits the proteasome. PI-1840 has been shown to be effective against human cancer cells in culture and has potential as an anticancer agent.

Formula: C₂₂H₂₆N₄O₃

Purity: Min. 95%

Molecular weight: 394.47 g/mol

Ref: 3D-BGC22322